Literature DB >> 16478202

Experimental and computational studies on the mechanism of N-heterocycle C-H activation by Rh(I).

Sean H Wiedemann1, Jared C Lewis, Jonathan A Ellman, Robert G Bergman.   

Abstract

Evidence is presented for a proposed mechanism of C-H activation of 3-methyl-3,4-dihydroquinazoline (1) by (PCy(3))(2)RhCl. One intermediate (3), a coordination complex of 1 with (PCy(3))(2)RhCl, was identified along the path to the Rh-N-heterocyclic carbene product of this reaction (2). Isotopic labeling and reaction-rate studies were used to demonstrate that C-H activation takes place intramolecularly on the reaction coordinate between 3 and 2. Computational studies corroborate the proposed mechanism and suggest that the rate-limiting step is oxidative addition of the C-H bond to the metal center. The consequences of this mechanism for coupling reactions of N-heterocycles that occur via Rh-catalyzed C-H bond activation are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16478202      PMCID: PMC2585050          DOI: 10.1021/ja0576684

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  36 in total

1.  New strategies in organic catalysis: the first enantioselective organocatalytic Friedel-Crafts alkylation.

Authors:  N A Paras; D W MacMillan
Journal:  J Am Chem Soc       Date:  2001-05-09       Impact factor: 15.419

2.  Annulation of alkenyl-substituted heterocycles via rhodium-catalyzed intramolecular C-H activated coupling reactions.

Authors:  K L Tan; R G Bergman; J A Ellman
Journal:  J Am Chem Soc       Date:  2001-03-21       Impact factor: 15.419

3.  Stable Carbenes.

Authors:  Didier Bourissou; Olivier Guerret; François P. Gabbaï; Guy Bertrand
Journal:  Chem Rev       Date:  2000-01-12       Impact factor: 60.622

4.  Ru-, Rh-, and Pd-catalyzed C-C bond formation involving C-H activation and addition on unsaturated substrates: reactions and mechanistic aspects.

Authors:  Vincent Ritleng; Claude Sirlin; Michel Pfeffer
Journal:  Chem Rev       Date:  2002-05       Impact factor: 60.622

5.  A Search for pi/sigma Equilibria in Chiral Rhenium Imine Complexes of the Formula [(eta(5)-C(5)H(5))Re(NO)(PPh(3))(N(H)=C(CF(3))X)](+)TfO(-): Investigation of Electronic Effects upon the Binding Mode.

Authors:  Gene A. Stark; J. A. Gladysz
Journal:  Inorg Chem       Date:  1996-09-11       Impact factor: 5.165

6.  Enantioselective organocatalytic indole alkylations. Design of a new and highly effective chiral amine for iminium catalysis.

Authors:  Joel F Austin; David W C MacMillan
Journal:  J Am Chem Soc       Date:  2002-02-20       Impact factor: 15.419

7.  Intermediacy of an N-heterocyclic carbene complex in the catalytic C-H activation of a substituted benzimidazole.

Authors:  Kian L Tan; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2002-04-03       Impact factor: 15.419

8.  Acylation of five-membered N-heteroaromatic compounds by ruthenium carbonyl-catalyzed direct carbonylation at a C-H bond

Authors: 
Journal:  J Org Chem       Date:  2000-06-30       Impact factor: 4.354

9.  A general and efficient copper catalyst for the amidation of aryl halides.

Authors:  Artis Klapars; Xiaohua Huang; Stephen L Buchwald
Journal:  J Am Chem Soc       Date:  2002-06-26       Impact factor: 15.419

10.  Abnormal ligand binding and reversible ring hydrogenation in the reaction of imidazolium salts with IrH(5)(PPh(3))(2).

Authors:  Stephan Gründemann; Anes Kovacevic; Martin Albrecht; Jack W Faller; Robert H Crabtree
Journal:  J Am Chem Soc       Date:  2002-09-04       Impact factor: 15.419

View more
  16 in total

1.  Rh(I)-catalyzed direct arylation of azines.

Authors:  Ashley M Berman; Robert G Bergman; Jonathan A Ellman
Journal:  J Org Chem       Date:  2010-10-29       Impact factor: 4.354

2.  Synthesis of potent bicyclic bisarylimidazole c-Jun N-terminal kinase inhibitors by catalytic C-H bond activation.

Authors:  Jason C Rech; Michihisa Yato; Derek Duckett; Brian Ember; Philip V LoGrasso; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2007-01-24       Impact factor: 15.419

3.  Palladium-catalyzed direct functionalization of imidazolinone: synthesis of dibromophakellstatin.

Authors:  Jianming Lu; Xianghui Tan; Chuo Chen
Journal:  J Am Chem Soc       Date:  2007-06-01       Impact factor: 15.419

4.  Synthesis of dihydropyridines and pyridines from imines and alkynes via C-H activation.

Authors:  Denise A Colby; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2008-02-27       Impact factor: 15.419

5.  Rh(I)-catalyzed alkylation of quinolines and pyridines via C-H bond activation.

Authors:  Jared C Lewis; Robert G Bergman; Jonathan A Ellman
Journal:  J Am Chem Soc       Date:  2007-04-06       Impact factor: 15.419

6.  Synthesis of a Benzodiazepine-derived Rhodium NHC Complex by C-H Bond Activation.

Authors:  Michael W Gribble; Jonathan A Ellman; Robert G Bergman
Journal:  Organometallics       Date:  2008-05-26       Impact factor: 3.876

7.  Rhodium catalyzed enantioselective cyclization of substituted imidazoles via C-H bond activation.

Authors:  Andy S Tsai; Rebecca M Wilson; Hitoshi Harada; Robert G Bergman; Jonathan A Ellman
Journal:  Chem Commun (Camb)       Date:  2009-06-02       Impact factor: 6.222

Review 8.  Direct functionalization of nitrogen heterocycles via Rh-catalyzed C-H bond activation.

Authors:  Jared C Lewis; Robert G Bergman; Jonathan A Ellman
Journal:  Acc Chem Res       Date:  2008-07-11       Impact factor: 22.384

Review 9.  Rhodium-catalyzed C-C bond formation via heteroatom-directed C-H bond activation.

Authors:  Denise A Colby; Robert G Bergman; Jonathan A Ellman
Journal:  Chem Rev       Date:  2010-02-10       Impact factor: 60.622

10.  Computational prediction of the regio- and diastereoselectivity in a rhodium-catalyzed hydroformylation/cyclization domino process.

Authors:  Giuliano Alagona; Caterina Ghio; Silvia Rocchiccioli
Journal:  J Mol Model       Date:  2007-05-22       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.